dc.date.accessioned2022-01-18T19:34:43Z
dc.date.available2022-01-18T19:34:43Z
dc.date.created2022-01-18T19:34:43Z
dc.date.issued2011
dc.identifierhttps://hdl.handle.net/20.500.12866/11191
dc.identifierhttps://doi.org/10.1645/GE-2420.1
dc.description.abstractWe have evaluated the possible mechanisms of liver fibrosis caused by Fasciola hepatica in an animal model and in culture using immortalized human stellate cells. Liver biopsies of F. hepatica-infected rats were performed at wk 8 and 16. Serum-starved LX-2 cells, a human stellate cell line, were exposed to increasing concentrations of Fas2 antigen. The expression of key fibrosis-related genes was evaluated by qRT-PCR. There was a significant correlation between fibrogenic gene expression and both intensity and duration of infection. LX-2 cells exposed to Fas2 showed progressively increased expression of mRNAs for Collagen I, alpha-smooth muscle-actin, platelet-derived growth factor beta receptor, and tissue inhibitor of metalloproteinase II; inhibition of Fas2 cysteine proteinase activity by E-64 abrogated these increases, suggesting that the protease activity of Fas2 is involved in fibrogenic stimulation. In summary, F. hepatica infection is associated with up-regulation of mRNAs associated with hepatic fibrogenesis in vivo and in activated hepatic stellate cells.
dc.languageeng
dc.publisherAmerican Society of Parasitologists
dc.relationJournal of Parasitology
dc.relation1937-2345
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectHumans|controlled study
dc.subjectpathology
dc.subjectanimal
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectAnimals
dc.subjectcollagen type 1
dc.subjectgenetics
dc.subjectin vitro study
dc.subjectin vivo study
dc.subjectmetabolism
dc.subjectnon|physiology
dc.subjectpathogenicity
dc.subjectpolymerase chain reaction
dc.subjectinfectious disease
dc.subjectparasite antigen
dc.subjectunclassified drug
dc.subjectdisease association
dc.subjectgene expression
dc.subjectDisease Models, Animal
dc.subjectAnalysis of Variance
dc.subjectCell Line
dc.subjectmessenger RNA
dc.subjectupregulation
dc.subjectdisease model
dc.subjectreal time polymerase chain reaction
dc.subjectenzymology
dc.subjecttissue inhibitor of metalloproteinase 1
dc.subjectFasciola hepatica
dc.subjectFascioliasis
dc.subjectenzyme activity
dc.subjectAnimalia
dc.subjectAntigens, Helminth
dc.subjectcysteine proteinase
dc.subjectRats
dc.subjectanalysis of variance
dc.subjectGene Expression
dc.subjectfunctional morphology
dc.subjectgenetic analysis
dc.subjectnumerical model
dc.subjectgelatinase A
dc.subjectexperimental study
dc.subjecttransforming growth factor beta1
dc.subjectRattus
dc.subjectActins
dc.subjectalpha smooth muscle actin
dc.subjectantigen
dc.subjectcell activation
dc.subjectcell organelle
dc.subjectCollagen
dc.subjectCysteine Endopeptidases
dc.subjectFas antigen
dc.subjectFas2 antigen
dc.subjectFas2 antigen, Fasciola hepatica
dc.subjectfibrogenesis
dc.subjectflatworm
dc.subjectHepatic Stellate Cells
dc.subjectinhibitor
dc.subjectliver biopsy
dc.subjectLiver Cirrhosis
dc.subjectliver fibrosis
dc.subjectn [n (3 carboxyoxirane 2 carbonyl)leucyl]agmatine
dc.subjectplatelet derived growth factor beta receptor
dc.subjectReceptor, Platelet-Derived Growth Factor beta
dc.subjectstellate cell
dc.subjecttissue inhibitor of metalloproteinase 2
dc.subjectTissue Inhibitor of Metalloproteinase-2
dc.titleMechanisms of liver fibrosis associated with experimental fasciola hepatica infection: Roles of Fas2 proteinase and hepatic stellate cell activation
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución